Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00138
|
|||||
| Drug Name |
Bicarbonate
|
|||||
| Synonyms |
71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Metabolic acidosis [ICD11: 5C73] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
CHO3-
|
|||||
| Canonical SMILES |
C(=O)(O)[O-]
|
|||||
| InChI |
InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1
|
|||||
| InChIKey |
BVKZGUZCCUSVTD-UHFFFAOYSA-M
|
|||||
| CAS Number |
CAS 71-52-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 61.017 | Topological Polar Surface Area | 60.4 | ||
| Heavy Atom Count | 4 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
0.5
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17544
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | AE2 | Transporter Info | Anion exchange protein 2 | Substrate | [2] | |
| AE3 | Transporter Info | Anion exchange protein 3 | Substrate | [3] | ||
| SAT1 | Transporter Info | Sulfate anion transporter 1 | Substrate | [4] | ||
| SLC26A6 | Transporter Info | Anion exchange transporter | Substrate | [5] | ||
| SLC26A7 | Transporter Info | Anion exchange transporter | Substrate | [6] | ||
| SLC26A9 | Transporter Info | Anion transporter/exchanger protein 9 | Substrate | [7] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01640119) Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD) | |||||
| 2 | HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function. Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16934-9. | |||||
| 3 | The SLC4 family of bicarbonate (HCO??) transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):159-82. | |||||
| 4 | SLC26A Gene Family Participate in pH Regulation during Enamel Maturation. PLoS One. 2015 Dec 15;10(12):e0144703. | |||||
| 5 | Metabolon disruption: a mechanism that regulates bicarbonate transport. EMBO J. 2005 Jul 20;24(14):2499-511. | |||||
| 6 | Vasopressin induces expression of the Cl-/HCO3- exchanger SLC26A7 in kidney medullary collecting ducts of Brattleboro rats. Am J Physiol Renal Physiol. 2006 May;290(5):F1194-201. | |||||
| 7 | SLC26A9 is expressed in gastric surface epithelial cells, mediates Cl-/HCO3- exchange, and is inhibited by NH4+. Am J Physiol Cell Physiol. 2005 Aug;289(2):C493-505. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.